Trevor Pitcher, PhD

Senior Director, Biodesix Inc.

Dr. Trevor Pitcher has served as the Sr. Director of Medical Affairs with Biodesix Inc. since 2017. Prior to joining Biodesix, he worked as the Director of Scientific Affairs for Laboratory Sciences at The Binding Site (USA). Dr. Pitcher received his Ph.D in experimental pathology from the University of Texas Medical Branch in Galveston, Texas and conducted his post-doctoral work in clinical chemistry and toxicology at the University of Louisville, Kentucky. Dr. Pitcher is also a board-certified clinical chemist through the American Board of Clinical Chemistry.

Harnessing the Power of ddPCR to Advance Precision Oncology

Liquid biopsies and the advent of blood-based diagnostics have emerged in recent years as promising alternatives and complements to tissue-based genomic and proteomic assays. Biodesix, a global leader in molecular diagnostics and assay design/development, leverages cutting-edge technology, including droplet digital PCR (ddPCR), to advance translational and clinical oncology research and to assist biopharma companies in delivering new, targeted, life-saving therapies to patients.

This presentation provides a comprehensive exploration of new blood-based diagnostics, including the development of a microsatellite instability (MSI) test on the ddPCR platform and the dynamic monitoring capabilities of ddPCR using circulating tumor DNA (ctDNA).

Online Event

The Landscape of Cancer Research 2023

On June 28-29 join us for an insightful two-day online event featuring renowned experts who will share their innovative work in cancer research. Don't miss out on this opportunity to stay up-to-date on the latest developments in these fields and network with fellow professionals.